HCC
GDRX icon

Hirtle Callaghan & Co’s GoodRx Holdings GDRX Stock Holding History

Hirtle Callaghan & Co’s Portfolio GDRX Stock Details GDRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$52.6K Hold
18,261
– – ﹤0.01% 128
2026
Q1 		$35.8K Hold
18,261
– – ﹤0.01% 112
2025
Q4 		$49.5K Buy
18,261
+6,869
+60% +$22.6K ﹤0.01% 110
2025
Q3 		$48.2K Buy
+11,392
New +$50.1K ﹤0.01% 100

Other funds holding GDRX

FPM
Francisco Partners Management San Francisco, California $361M AUM 30.56% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SLG
Silver Lake Group Menlo Park, California $4.58B AUM 24.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
PTC
Petrus Trust Company Dallas, Texas $1.06B AUM 4.66% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Hirtle Callaghan & Co's GDRX Position: Q2 2026 in Review

Hirtle Callaghan & Co held its GoodRx Holdings (GDRX) position steady in Q2 2026 at 18,261 shares worth $52.6K. The position accounts for ﹤0.01% of the portfolio, ranked #128.

Hirtle Callaghan & Co first reported a position in GDRX in Q3 2025 and has held it in 4 quarters since. 162 funds tracked by Wall St. Rank hold GDRX as of Q2 2026.

  • Hirtle Callaghan & Co held 18,261 shares of GoodRx Holdings worth $52.6K as of Q2 2026.
  • Hirtle Callaghan & Co left its GoodRx Holdings share count unchanged in Q2 2026.
  • GoodRx Holdings made up ﹤0.01% of Hirtle Callaghan & Co's portfolio in Q2 2026, its #128 holding.
  • Hirtle Callaghan & Co first reported a position in GoodRx Holdings in Q3 2025 and has held it in 4 quarters since.
  • 162 funds tracked by Wall St. Rank held GoodRx Holdings as of Q2 2026.

Based on Hirtle Callaghan & Co's 13F filing for Q2 2026, filed 14 Aug 2026.